An Open, Multicenter Phase II Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Latest Information Update: 03 Jun 2025
At a glance
- Drugs Adebrelimab (Primary) ; SHR 8068 (Primary) ; Trastuzumab rezetecan (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
Most Recent Events
- 10 Mar 2025 New trial record